Vivos (RDGL) Non-Current Assets (2010 - 2025)

Vivos' (RDGL) quarterly Non-Current Assets came in at $216514.0 in Q4 2025, up 32263.83% quarter-over-quarter from $669.0 in Q3 2018.

Vivos (RDGL) Non-Current Assets (2010 - 2025) Analysis & Trends

Vivos has disclosed Non-Current Assets across 10 years of filings, most recently posting $216514.0 for Q4 2025.

Non-Current Assets for Q4 2025 came in at $216514.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $216514.0 (changed N/A YoY), and the FY2025 annual result was $216514.0, changed N/A from the prior year.
Non-Current Assets came in at $216514.0 for Q4 2025 at Vivos, up from $669.0 in the prior quarter.
In the past five years, Non-Current Assets ranged from a high of $216514.0 in Q4 2025 to a low of $216514.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Assets (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn	84.92 Bn
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn	32.95 Bn
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn	67.41 Bn
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn	35.67 Bn
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn	7.09 Bn
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn	26.70 Bn
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	20.47 Bn
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn	2.30 Bn
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn	8.34 Bn
10	Vivos	-	-	-3,105.00	216,514.00

Download Data